Connection

Francois Lamontagne to Drug Combinations

Back to Details
This is a "connection" page, showing publications Francois Lamontagne has written about Drug Combinations.
Francois Lamontagne
Connection Strength
0.077
Drug Combinations
  1. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
    View in: PubMed
    Score: 0.028
  2. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
    View in: PubMed
    Score: 0.026
  3. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis. 2019 May 02; 19(1):376.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.